(-0.68%) 5 072.75 points
(-0.54%) 38 473 points
(-1.05%) 17 479 points
(0.35%) $83.10
(-0.30%) $1.648
(0.16%) $2 342.10
(0.40%) $27.46
(-0.14%) $914.50
(-0.16%) $0.933
(-0.42%) $10.94
(-0.38%) $0.799
(-0.29%) $92.05
Live Chart Being Loaded With Signals
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States...
Stats | |
---|---|
Today's Volume | 281.00 |
Average Volume | 14 564.00 |
Market Cap | 449.99M |
EPS | $-0.178 ( 2023-09-29 ) |
Last Dividend | $0.555 ( 2023-10-05 ) |
Next Dividend | $0 ( N/A ) |
P/E | -9.97 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-11-13 | Schreiber Justin | Buy | 50 000 | Common Stock |
2023-11-06 | Jindal Piyush | Buy | 37 500 | Common Stock |
2023-11-06 | Jindal Piyush | Sell | 37 500 | Stock Option (Right to Buy) |
2023-06-13 | Velge Bertrand | Buy | 49 465 | Common Stock |
2023-06-07 | Velge Bertrand | Buy | 24 500 | Common Stock |
INSIDER POWER |
---|
42.72 |
Last 50 transactions |
Buy: 2 415 167 | Sell: 887 500 |
LifeMD, Inc. Correlation
10 Most Positive Correlations | |
---|---|
UCL | 0.831 |
PLRX | 0.83 |
PALT | 0.829 |
SOHO | 0.822 |
XBIO | 0.816 |
YTEN | 0.815 |
NVFY | 0.803 |
DCGO | 0.801 |
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
LifeMD, Inc. Financials
Annual | 2023 |
Revenue: | $152.55M |
Gross Profit: | $126.01M (82.61 %) |
EPS: | $-0.610 |
Q4 | 2023 |
Revenue: | $44.86M |
Gross Profit: | $37.45M (83.47 %) |
EPS: | $-0.100 |
Q3 | 2023 |
Revenue: | $38.61M |
Gross Profit: | $33.83M (87.62 %) |
EPS: | $-0.180 |
Q2 | 2023 |
Revenue: | $35.95M |
Gross Profit: | $31.40M (87.35 %) |
EPS: | $-0.210 |
Financial Reports:
No articles found.
LifeMD, Inc. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.555 (N/A) |
$0.555 (N/A) |
$0.555 (N/A) |
$0.555 (N/A) |
$0.555 (N/A) |
$0.555 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.622 | 2022-01-03 |
Last Dividend | $0.555 | 2023-10-05 |
Next Dividend | $0 | N/A |
Payout Date | 2023-10-16 | |
Next Payout Date | N/A | |
# dividends | 8 | -- |
Total Paid Out | $4.51 | -- |
Avg. Dividend % Per Year | 7.37% | -- |
Score | 5.92 | -- |
Div. Sustainability Score | 6.99 | |
Div.Growth Potential Score | 2.29 | |
Div. Directional Score | 4.64 | -- |
Year | Amount | Yield |
---|---|---|
2022 | $2.29 | 12.40% |
2023 | $2.22 | 15.90% |
2024 | $0 | 0.00% |
With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.175 | 1.500 | -3.50 | -5.25 | [0 - 0.5] |
returnOnAssetsTTM | -0.456 | 1.200 | -10.00 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | 3.88 | 1.500 | 10.00 | 10.00 | [0.1 - 1] |
payoutRatioTTM | -0.116 | -1.000 | -1.165 | 1.165 | [0 - 1] |
currentRatioTTM | 1.225 | 0.800 | 8.88 | 7.10 | [1 - 3] |
quickRatioTTM | 1.105 | 0.800 | 8.21 | 6.57 | [0.8 - 2.5] |
cashRatioTTM | 0.953 | 1.500 | 5.82 | 8.73 | [0.2 - 2] |
debtRatioTTM | 0.322 | -1.500 | 4.63 | -6.94 | [0 - 0.6] |
interestCoverageTTM | -5.58 | 1.000 | -3.18 | -3.18 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.240 | 2.00 | 9.92 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.00237 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 5.38 | -1.500 | 10.00 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.863 | 1.000 | 10.00 | 10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.0950 | 1.000 | -3.90 | -3.90 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.468 | 1.000 | 8.51 | 8.51 | [0.2 - 2] |
assetTurnoverTTM | 2.61 | 0.800 | 10.00 | 8.00 | [0.5 - 2] |
Total Score | 6.99 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -15.36 | 1.000 | -1.653 | 0 | [1 - 100] |
returnOnEquityTTM | 3.88 | 2.50 | 10.00 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.00237 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.240 | 2.00 | 9.92 | 10.00 | [0 - 30] |
payoutRatioTTM | -0.116 | 1.500 | -1.165 | 1.165 | [0 - 1] |
pegRatioTTM | 0.233 | 1.500 | -1.778 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0578 | 1.000 | -1.055 | 0 | [0.1 - 0.5] |
Total Score | 2.29 |
LifeMD, Inc.
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators